Category Archives : News

Home  >>  News

EMBL: PDX Finder – Free global portal for cancer models

On April 9, 2018, Posted by , In News, By , With Comments Off on EMBL: PDX Finder – Free global portal for cancer models

First global online catalogue of PDX models facilitates collaboration and helps cancer researchers save valuable time The European Bioinformatics Institute (EMBL-EBI) and The Jackson Laboratory (JAX) have jointly developed the first open cancer research portal for Patient Derived Xenograft (PDX) models. The freely available PDX Finder is hosted by EMBL-EBI…

New member: Welcome to PEKKIP Oncology Alliance in our cluster

On April 4, 2018, Posted by , In News, By , With Comments Off on New member: Welcome to PEKKIP Oncology Alliance in our cluster

We are happy to welcome in our cluster PEKKIP Oncology Alliance.   “Fighting cancer needs genius and expertise – but prior to all it needs cooperation.” Ahmet Sami Pekkip – CEO PEKKIP Oncology Alliance have an excellent network of internationally renowned key opinion leaders at hand. They use this pool…

Remote Learning: new Master in Biotechnology (M.Sc.) starts in the winter semester 2018

On April 4, 2018, Posted by , In News, By , With Comments Off on Remote Learning: new Master in Biotechnology (M.Sc.) starts in the winter semester 2018

Esslingen University of Applied Sciences together with the scientific publisher Springer, established a new remote learning Master in Biotechnology. This Master is the perfect solution for professionals who want to continue their education, without leaving their job. After 5,5 semesters, the students will receive a Master of Science (M.Sc.) in…

HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

On April 4, 2018, Posted by , In News, By ,, , With Comments Off on HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

Two awards at once, both carrying high monetary prizes, go to young researchers from the Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ): Simon Raffel will receive the 2018 Walter Schulz Prize for his discovery how misregulated breakdown of amino acids…

Heidelberg, Paris, Prague and Warsaw Build European University Alliance

On March 22, 2018, Posted by , In News, By , , With Comments Off on Heidelberg, Paris, Prague and Warsaw Build European University Alliance

Signing of the declaration on the founding of the European University Alliance “4EU“: From left to right, Prof. Dr Marcin Palys (University of Warsaw), Prof. Dr Jean Chambaz (Sorbonne University), Prof. Dr Bernhard Eitel (Heidelberg University) and Vice-President Prof. Dr Lenka Rovná (on behalf of the President of Charles University…

Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death of advanced squamous lung cancer

On March 21, 2018, Posted by , In News, By , , With Comments Off on Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death of advanced squamous lung cancer

Phase III IMpower131 study showed Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met…

HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

On March 21, 2018, Posted by , In News, By , , With Comments Off on HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

HI-STEM, the Heidelberg Institute for Stem Cell Technology and Experimental Medicine at the German Cancer Research Center (DKFZ), is looking back on ten successful years. In numerous types of cancer, HI-STEM researchers have been able to show the role of stem cells in the development, spread and therapy resistance of…

Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

On March 20, 2018, Posted by , In News, By ,, , With Comments Off on Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

Boehringer Ingelheim and Vanderbilt University announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research partnership will focus on the discovery and development of new chemical therapeutics targeting the pro-survival protein MCL1 as a potential therapy against MCL1 dependent cancers. This is the third…

New member: Welcome to PAASP in our cluster

On March 15, 2018, Posted by , In News, By , With Comments Off on New member: Welcome to PAASP in our cluster

We are happy to welcome in our cluster PAASP GmbH (Partnership for Assessment and Accreditation of Scientific Practice). “Quality in Research is the basis for the development of novel drugs.” Anton Bespalov, CEO The PAASP GmbH is a full-service consulting and auditing company that specializes on providing assessment of operational…

Sciomics: Solving Alzheimers with this company’s new approach?

On March 14, 2018, Posted by , In News, By , , With Comments Off on Sciomics: Solving Alzheimers with this company’s new approach?

Labiotech.eu media recently profiled our member Sciomics, a German Cancer Research Center (DKFZ) spin-off founded in 2013 by a team of researchers led by Dr. Christoph Schröder and Dr. Jörg Hoheisel. Sciomics has developed antibody microarrays as a tool for analyzing complex protein samples. Using their expertise, they are able to address…